Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Bristol-Myers Squibb Company
FDA Inspection
•Bristol-Myers Squibb Company•June 16, 2023

Bristol-Myers Squibb Company – FDA Inspection, Jun 16, 2023

Record Details

This FDA Inspection record concerns Bristol-Myers Squibb Company, with an inspection on June 16, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Bristol-Myers Squibb Company
Inspection Date
June 16, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Emily A. Walters (Company Rep)
  • Helen B. Ricalde (FDA Associated Person)
  • Unnee Ranjan (FDA Associated Person)
View Company Profile

ID · ad863020-b34a-40d2-91ba-237fdca75cc3

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1208871
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.137(a)Expiration date lacking
  3. 21 CFR 211.42(c)(5)Mfg / Processing Operations Area
  4. 21 CFR 211.100(a)Absence of Written Procedures
  5. 21 CFR 211.100(a)Absence of Written Procedures
  6. 21 CFR 211.137(a)Expiration date lacking
  7. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  8. 21 CFR 211.42(c)(5)Mfg / Processing Operations Area

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Bristol-Myers Squibb Company

16
DateClassificationOfficeProject area
June 23, 2026Not classifiedNew Jersey District Office
July 18, 2025Not classifiedNew Jersey District Office
December 6, 2024VAINew Jersey District OfficePostmarketing Surveillance and Epidemiology: Human Drugs
September 6, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
January 31, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 16 other inspections on the company page
Other documents for Bristol-Myers Squibb Company
  • FDA Inspection 1327472 - 2026-06-23
  • FDA Inspection 1275526 - 2025-07-18
  • FDA Inspection 1236864 - 2024-12-06
  • FDA Inspection 1247735 - 2024-09-06
  • FDA Inspection 1228973 - 2024-01-31

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bristol-Myers Squibb Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.